• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

(Z)-和(E)-4-羟基他莫昔芬的非异构化类似物。取代二苯基苯并环庚烯的合成及内分泌特性

Nonisomerizable analogues of (Z)- and (E)-4-hydroxytamoxifen. Synthesis and endocrinological properties of substituted diphenylbenzocycloheptenes.

作者信息

McCague R, Leclercq G, Jordan V C

机构信息

Drug Development Section, Institute of Cancer Research, Sutton, Surrey, U.K.

出版信息

J Med Chem. 1988 Jul;31(7):1285-90. doi: 10.1021/jm00402a005.

DOI:10.1021/jm00402a005
PMID:3385723
Abstract

Substituted 8,9-diphenyl-6,7-dihydro-5H-benzocycloheptenes 6-8, which are ring-fused analogues of (Z)-trans-4-hydroxytamoxifen, (E)-cis-tamoxifen, and (E)-cis-4-hydroxytamoxifen, were synthesized from 7-methoxy-1-benzosuberone. The hydroxy compounds 6 and 8 were individually prepared via a common synthetic intermediate from which either the perfluoro-p-tolyl or the methyl ether functions could be cleaved specifically. Compounds were assayed for binding affinity to estrogen receptors in cytosol and in MCF-7 whole cells and for growth inhibition of MCF-7 cells in vitro and rat uteri in vivo. The endocrinological properties of the cyclic analogues 5-7 paralleled those of the corresponding derivatives of tamoxifen although in the MCF-7 assay 6 was slightly less effective than 4-hydroxytamoxifen at 10(-6) and 10(-7) M. The compound 8 analogues to cis-4-hydroxytamoxifen antagonized the growth stimulation by estradiol of MCF-7 cell or rat uterus growth, and it is therefore an antiestrogen, but its potency was somewhat less, both as an antiestrogen and an estrogen, than reported for cis-4-hydroxytamoxifen attributable to modification of the biochemical properties of the latter by isomerization to the more potent trans isomer. Curiously, in the absence of estradiol, compound 8 stimulated MCF-7 cell growth at low concentration (10(-8) M) but inhibited growth at higher concentration. In contrast, compound 7, which lacked the hydroxy function, was a full estrogen in the rat uterine growth assay. These compounds should be ideal for further structure-activity studies of triarylethylene-based antiestrogens without complications caused by isomerization.

摘要

取代的8,9 - 二苯基 - 6,7 - 二氢 - 5H - 苯并环庚烯6 - 8是(Z)-反式 - 4 - 羟基他莫昔芬、(E)-顺式 - 他莫昔芬和(E)-顺式 - 4 - 羟基他莫昔芬的稠环类似物,由7 - 甲氧基 - 1 - 苯并环庚酮合成。羟基化合物6和8分别通过一种常见的合成中间体制备,从中可以特异性地裂解全氟对甲苯基或甲基醚官能团。对化合物进行了测定,以检测其对胞质溶胶和MCF - 7全细胞中雌激素受体的结合亲和力,以及对MCF - 7细胞的体外生长抑制和对大鼠子宫的体内生长抑制。环状类似物5 - 7的内分泌特性与他莫昔芬相应衍生物的特性相似,尽管在MCF - 7试验中,在10(-6)和10(-7) M浓度下,6的效果略低于4 - 羟基他莫昔芬。与顺式 - 4 - 羟基他莫昔芬类似的化合物8拮抗了雌二醇对MCF - 7细胞生长或大鼠子宫生长的刺激作用,因此它是一种抗雌激素,但作为抗雌激素和雌激素,其效力均略低于报道的顺式 - 4 - 羟基他莫昔芬,这归因于后者通过异构化为更有效的反式异构体而改变了生化性质。奇怪的是,在没有雌二醇的情况下,化合物8在低浓度(10(-8) M)时刺激MCF - 7细胞生长,但在高浓度时抑制生长。相比之下,缺乏羟基官能团的化合物7在大鼠子宫生长试验中是一种完全的雌激素。这些化合物对于基于三芳基乙烯的抗雌激素的进一步构效关系研究应该是理想的,不会因异构化而产生并发症。

相似文献

1
Nonisomerizable analogues of (Z)- and (E)-4-hydroxytamoxifen. Synthesis and endocrinological properties of substituted diphenylbenzocycloheptenes.(Z)-和(E)-4-羟基他莫昔芬的非异构化类似物。取代二苯基苯并环庚烯的合成及内分泌特性
J Med Chem. 1988 Jul;31(7):1285-90. doi: 10.1021/jm00402a005.
2
Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.他莫昔芬和羟基他莫昔芬异构体在MCF-7人乳腺癌细胞中的生物活性、雌激素受体相互作用及纤溶酶原激活剂诱导活性
Cancer Res. 1984 Jan;44(1):112-9.
3
Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.他莫昔芬不可异构化衍生物的构效关系:羟基和侧链位置对生物活性的重要性。
Mol Pharmacol. 1991 Mar;39(3):421-8.
4
Hydroxy derivatives of tamoxifen.他莫昔芬的羟基衍生物。
J Med Chem. 1985 Oct;28(10):1491-7. doi: 10.1021/jm00148a020.
5
Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.抗雌激素在MCF-7人乳腺癌细胞的抗雌激素生长抗性雌激素反应性克隆变体中的结合。
Cancer Res. 1984 Nov;44(11):5038-45.
6
Synthesis, conformational considerations, and estrogen receptor binding of diastereoisomers and enantiomers of 1-[4-[2-(dimethylamino)ethoxy]phenyl]-1,2-diphenylbutane (dihydrotamoxifen).1-[4-[2-(二甲基氨基)乙氧基]苯基]-1,2-二苯基丁烷(二氢他莫昔芬)的非对映异构体和对映异构体的合成、构象分析及雌激素受体结合
J Med Chem. 1987 Oct;30(10):1761-7. doi: 10.1021/jm00393a014.
7
Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitro.他莫昔芬羟基化代谢产物的结构-功能关系,其在体外控制雌激素反应性T47D乳腺癌细胞的增殖。
Mol Pharmacol. 1990 Nov;38(5):737-43.
8
Biological activities of tamoxifen aziridine, an antiestrogen-based affinity label for the estrogen receptor, in vivo and in vitro.他莫昔芬氮丙啶(一种基于抗雌激素的雌激素受体亲和标记物)的体内和体外生物学活性。
J Steroid Biochem. 1985 Dec;23(6A):875-81. doi: 10.1016/0022-4731(85)90042-1.
9
Investigation of the mechanism of tamoxifen-stimulated breast tumor growth with nonisomerizable analogues of tamoxifen and metabolites.用他莫昔芬的非异构化类似物和代谢物研究他莫昔芬刺激乳腺肿瘤生长的机制。
J Natl Cancer Inst. 1993 May 19;85(10):806-12. doi: 10.1093/jnci/85.10.806.
10
Antiestrogenic action of 3-hydroxytamoxifen in the human breast cancer cell line MCF-7.3-羟基他莫昔芬在人乳腺癌细胞系MCF-7中的抗雌激素作用。
J Natl Cancer Inst. 1983 Jul;71(1):55-9.

引用本文的文献

1
Selective synthesis of either enantiomer of an anti-breast cancer agent via a common enantioenriched intermediate.通过一个常见的对映体富集中间体选择性合成一种抗乳腺癌药物的任意一种对映体。
Tetrahedron Lett. 2015 Jun 3;56(23):3486-3488. doi: 10.1016/j.tetlet.2015.02.121.
2
Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer.他莫昔芬代谢可预测绝经前早期乳腺癌患者的药物浓度及预后。
Pharmacogenomics J. 2015 Feb;15(1):84-94. doi: 10.1038/tpj.2014.34. Epub 2014 Aug 5.
3
Influence of the length and positioning of the antiestrogenic side chain of endoxifen and 4-hydroxytamoxifen on gene activation and growth of estrogen receptor positive cancer cells.
Endoxifen 和 4-羟基他莫昔芬的抗雌激素侧链的长度和定位对雌激素受体阳性癌细胞基因激活和生长的影响。
J Med Chem. 2014 Jun 12;57(11):4569-83. doi: 10.1021/jm500569h. Epub 2014 May 22.
4
The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growth.他莫昔芬代谢在他莫昔芬刺激的乳腺肿瘤生长中的重要性。
Cancer Chemother Pharmacol. 1994;34(2):89-95. doi: 10.1007/BF00685924.
5
Synthesis and in vitro receptor binding studies of fluorotamoxifen analogues.氟他莫昔芬类似物的合成及体外受体结合研究
Pharm Res. 1991 Feb;8(2):174-7. doi: 10.1023/a:1015879717742.